Faropenem sodium

法罗培南钠

Report date: 2022/05/17 17:49:40
NME

Base Information

Drug NameFaropenem sodium
Drug Alias NameFropenem sodium法罗培南二钠法罗培南FRPMfaropenem +[15] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibioticsSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Carbapenems antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsAcne VulgarisSkin Diseases, InfectiousBacterial Infections
Global Approved IndicationsAcne VulgarisSkin Diseases, InfectiousBacterial Infections
Approved Indications in ChinaAcne VulgarisSkin Diseases, InfectiousBacterial Infections
Original Approved Country/TerritoryJapan
Original Approved Date1997/01/01
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMaruho Pharmaceutical
China Registration ClassN/A

Develop Information

Active CompaniesLunan Better Pharmaceutical Co LtdShandong New Time Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAcne VulgarisSkin Diseases, InfectiousBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01DI03
Related LinksWikipediaKEGG